BT vs Eko Vet+

BT-Link Mobile is a smartphone application that enables you to monitor one of the Bionet patient monitors using an iPhone or iPad (max: 10.4") on the same network and to receive alarms from the selected Bionet veterinary monitor including the BM3Vet Touch, BM7Vet, and BM7Vet Pro. The App receives all numeric parameters and waveforms while capturing the patient’s numeric data and waveforms as images. In addition, the App can record and save numeric data to a PDF file. Caution: BT-Link Mobile doesn't work in background mode.

The Eko Vet+™ | CANINEBEAT® AI solution can detect and grade* canine murmurs in 5 seconds using an Eko digital stethoscope. Developed in collaboration with 50 leading veterinary cardiologists and validated on thousands of annotated canine heart sound recordings, it delivers consistent, expert-validated murmur assessments for dogs. Use Eko Vet+™ to: • Detect and grade* canine heart murmurs at the point of care using CANINEBEAT® AI. • Get AI-supported disease findings, including likely etiology and probable MMVD staging.** • Share findings in customizable PDF reports tailored for pet owners or clinical colleagues. • Turn invisible murmurs into visible audio graphs that owners can see and understand. • Record, play back, and save heart sound recordings from routine exams. • Build canine patient profiles to track cardiac health and track changes across visits. • Amplify and filter heart sounds using your Eko digital stethoscope — up to 40x sound amplification with advanced noise cancellation. CANINEBEAT® AI is intended for use by veterinarians and veterinary staff on canine patients only. Results are not a diagnosis and should be interpreted alongside a full clinical evaluation. Further investigation, such as echocardiography or radiography, may be needed. Visit ekohealth.com to learn more. Have questions or feedback? Contact us at support@ekohealth.com. *CANINEBEAT® AI analyzes heart sounds and classifies murmur loudness using a modified Levine intensity scale. **Murmur intensity is used to estimate the likelihood of MMVD disease stage based on a large, epidemiological canine study.¹ Disease stage classifications are based on ACVIM guidelines.² Definitive staging requires confirmation by diagnostic imaging. ¹The LISTEN Study. 2026. Publication in submission. ²Keene BW, Atkins CE, Bonagura JD, et al. ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. J Vet Intern Med. 2019;33:1127–1140. Terms of Service: https://support.ekohealth.com/hc/en-us/articles/13156765697563-Terms-of-Service Privacy Policy: https://support.ekohealth.com/hc/en-us/articles/13156748616731-Privacy-Policy © 2026 Eko Health, Inc.